ACE and kidney disorder: Understanding the mechanisms underlying the reno-protective association of genetic proxies for ACE inhibitors and CCBs in the context of the relative merits of different hypertensives in promoting population health would be valuable, with implications for drug development and repositioning in the treatment of kidney disease.